- Research works
- 22 ▲ 207% vs 2013–17
- Citations
- 1.5k 69.0 per fractional work
- Top-10% rate
- 6.6% record average 16.5%
- Open access
- 46% world 28%
Not ranked overall: NovaCell Technology (South Korea) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.1×. Every wedge is a field page.
Which keywords describe research at NovaCell Technology (South Korea)?
By fractional works in all years, weighted toward what it does more of than the world: Immunotherapy, Tumor Regression, Cancer Immunotherapy, Cancer, Gene Therapy, CAR T Cells, Chimeric Antigen Receptor and Glycosylation.
- Gene Therapy
- CAR T Cells
- Cancer Immunotherapy
- Tumor Regression
- Immunotherapy
- Cancer
- Inflammation
- Chimeric Antigen Receptor
- Glycosylation
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 9 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 9 words, with their numbers
- Immunotherapy2▲ 14×5 topics
- Tumor Regression2▲ 91×2 topics
- Cancer2▲ 5.3×14 topics
- Cancer Immunotherapy2▲ 46×2 topics
- Inflammation1▲ 2.7×10 topics
- CAR T Cells1▲ 120×1 topic
- Chimeric Antigen Receptor1▲ 120×1 topic
- Gene Therapy1▲ 20×4 topics
- Glycosylation1▲ 21×3 topics
Which research topics does NovaCell Technology (South Korea) publish most on?
By volume in 2022–2025: CAR-T cell therapy research, Cancer Research and Treatments, CRISPR and Genetic Engineering and Immune Cell Function and Interaction.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 CAR-T cell therapy research Oncology 1 works
- 2 Cancer Research and Treatments Biotechnology 1 works
- 3 CRISPR and Genetic Engineering Molecular Biology 0 works
- 4 Immune Cell Function and Interaction Immunology 0 works
- 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
- 6 Synthesis and Biological Evaluation Organic Chemistry 0 works
- 7 Cell Image Analysis Techniques Biophysics 0 works
- 8 Viral Infectious Diseases and Gene Expression in Insects Molecular Biology 0 works
- 9 Virus-based gene therapy research Genetics 0 works
- 10 T-cell and B-cell Immunology Immunology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has NovaCell Technology (South Korea)'s research output changed?
Output in 2018–2022 was 207% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Pohang
- Pohang University of Science and Technology
- Pohang Iron and Steel (South Korea)
- Research Institute of Industrial Science and Technology
- Handong Global University
- Asia Pacific Center for Theoretical Physics
- Korea Institute of Robot and Convergence
- Pohang TechnoPark (South Korea)
- Sunlin University
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.